Meeting
2019 Gastrointestinal Cancers Symposium
Temporal trends and disease characteristics associated with total neoadjuvant therapy (TNT) usage.
Authors
Laila Babar
The Esophageal and Lung Institute, Allegheny Health Network, Pittsburgh, PA
Laila Babar , Veli Bakalov , Stephen Abel , Gene Grant Finley , Moses S. Raj , Dulabh K. Monga , Alexander V. Kirichenko , Rodney E Wegner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 642)
DOI
10.1200/JCO.2019.37.4_suppl.642
Abstract #
642
Poster Bd #
L7
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy.
First Author: Paul Bernard Romesser
Poster
2023 ASCO Annual Meeting
Sustained organ preservation in rectal cancer patients treated with total neoadjuvant therapy: Long-term results of the OPRA trial.
First Author: Floris S Verheij
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant oxaliplatin-based therapy (TNT) before (induction) and after (consolidation) chemoradiation for advanced rectal cancer: MRI correlation on complete response and outcome.
First Author: Putao Cen
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.
First Author: Janice Zhao